$1.30
0.075.69%
At Close: -
$1.22
-0.08-6.08%
After Hours: Jul 24, 9:29 AM EDT
15 minutes delayed
Accelerate Diagnostics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Accelerate Diagnostics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AXDX | Accelerate Diagnostics | -$1.31 | -$0.55 | — | — | $2.92M | $3.01M | — | — | 08/08/2024 | Get Alert |
AXDX | Accelerate Diagnostics | -$1.71 | -$0.72 | -$0.88 | -22.22% | $2.81M | $3.00M | $2.92M | -2.63% | 05/08/2024 | Get Alert |
AXDX | Accelerate Diagnostics | -$0.15 | -$0.62 | -$0.89 | -43.55% | $2.97M | $3.45M | $3.03M | -12.26% | 03/28/2024 | Get Alert |
AXDX | Accelerate Diagnostics | -$1.80 | -$1.07 | -$1.18 | -10.28% | $2.96M | $3.53M | $3.30M | -6.54% | 11/09/2023 | Get Alert |
AXDX | Accelerate Diagnostics | -$2.30 | -$1.40 | -$1.31 | 6.43% | $3.86M | $3.60M | $2.92M | -18.86% | 08/10/2023 | Get Alert |
AXDX | Accelerate Diagnostics | -$2.50 | -$1.40 | -$1.70 | -21.43% | $2.96M | $3.35M | $2.81M | -16.06% | 05/11/2023 | Get Alert |
AXDX | Accelerate Diagnostics | -$2.30 | -$1.50 | -$1.50 | 0.00% | $303.00M | $2.87M | $2.97M | 3.55% | 03/29/2023 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.10 | -$1.90 | -$1.80 | 5.26% | $3.12M | $3.75M | $2.96M | -21.07% | 11/14/2022 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.60 | -$2.80 | -$2.30 | 17.86% | $2.80M | $3.00M | $3.86M | 28.70% | 08/15/2022 | Get Alert |
AXDX | Accelerate Diagnostics | -$4.10 | -$3.00 | -$2.50 | 16.67% | $2.52M | $2.95M | $2.96M | 0.27% | 05/16/2022 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.30 | -$2.50 | -$2.30 | 8.00% | $3.11M | $3.70M | $3.30M | -10.81% | 03/08/2022 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.30 | -$3.30 | -$3.10 | 6.06% | $3.59M | $3.91M | $3.12M | -20.15% | 11/09/2021 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.50 | -$3.30 | -$3.60 | -9.09% | $2.13M | $3.07M | $2.80M | -8.86% | 08/05/2021 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.90 | -$3.30 | -$4.10 | -24.24% | $2.34M | $3.10M | $2.52M | -18.77% | 05/06/2021 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.90 | -$3.20 | -$3.30 | -3.12% | — | $4.12M | $3.11M | -24.54% | 02/23/2021 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.70 | -$3.30 | -$3.30 | 0.00% | $2.27M | $3.27M | $3.59M | 9.72% | 11/05/2020 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.80 | -$3.40 | -$3.50 | -2.94% | $1.81M | $2.46M | $2.13M | -13.62% | 08/06/2020 | Get Alert |
AXDX | Accelerate Diagnostics | -$4.00 | -$3.80 | -$3.90 | -2.63% | $1.75M | $2.27M | $2.34M | 3.17% | 05/07/2020 | Get Alert |
AXDX | Accelerate Diagnostics | -$4.10 | -$4.00 | -$3.90 | 2.50% | $1.82M | — | $3.50M | — | 02/27/2020 | Get Alert |
AXDX | Accelerate Diagnostics | -$4.10 | -$3.80 | -$3.70 | 2.63% | $1.35M | $3.12M | $2.27M | -27.21% | 11/07/2019 | Get Alert |
AXDX | Accelerate Diagnostics | -$3.70 | -$3.90 | -$3.80 | 2.56% | $1.69M | $2.55M | $1.81M | -29.18% | 08/08/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $-0.88 | $-0.72 | -22.2 % |
Dec 2023 | 2024-03-28 | $-0.89 | $-0.62 | -43.5 % |
Sep 2023 | 2023-11-09 | $-1.18 | $-1.07 | -10.3 % |
Jun 2023 | 2023-08-10 | $-1.31 | $-1.40 | 6.43 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $2.92M | $3.00M | -2.63 % |
Dec 2023 | 2024-03-28 | $3.03M | $3.45M | -12.3 % |
Sep 2023 | 2023-11-09 | $3.30M | $3.53M | -6.54 % |
Jun 2023 | 2023-08-10 | $2.92M | $3.60M | -18.9 % |
Accelerate Diagnostics (AXDX) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
The Actual EPS was $-0.88, which missed the estimate of $-0.72.
The Actual Revenue was $2.9M, which missed the estimate of $3M.
Browse earnings estimates, EPS, and revenue on all stocks.